| | Call Details | Third Wave Technologies, Inc. Earnings Conference Call (Q4 2007) Tue,
Feb 26, 2008, 10:00 am Eastern
| | About Third Wave Technologies, Inc.
(NasdaqGM:TWTI) |
| | Third Wave Technologies, Inc. develops and markets molecular diagnostic products for various DNA and RNA analysis applications to clinical, research, and agricultural customers. The company provides its molecular solutions based on its Invader chemistry, a technology used in womens health, infectious disease, genetics and pharmacogenetics, and oncology segments. It offers inVitro diagnostic devices and analyte specific reagents. The companys analyte specific reagents allow laboratories to create assays to perform hepatitis C virus genotyping, inherited disorders testing, and a host of other mutations associated with genetic predispositions and other diseases. It provides physicians and researchers with molecular solutions for the analysis and treatment of disease. The company also develops various DNA and RNA analysis products for the research and agricultural biotechnology markets. Its customers include pharmaceutical and biotechnology companies, academic research centers, and health care providers. The company markets its products through an internal sales force, as well as collaborative relationships with pharmaceutical companies and research institutions in the United States and Europe. The company was founded in 1993 and is headquartered in Madison, Wisconsin. |
| More
Info:
Quote
|
Chart
|
News
|
Profile
|
Reports
|
Research
|
SEC
|
Msgs
|
Insider
|
Financials
|
Analyst Ratings |
|